Aurobindo Pharma Limited has informed the Exchange that Board of Directors at its meeting held on August 04, 2025, declared Interim Dividend of Rs. 4 per equity share.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Midcap 150 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aurobindo Pharma's Board of Directors, at its meeting on August 4, 2025, approved an interim dividend of Rs. 4.00 per equity share (400% on face value of Re. 1) for the financial year 2025-26. The company has fixed August 8, 2025, as the record date to determine eligible shareholders. The dividend will be paid on or before August 21, 2025. The board meeting was held from 4:30 PM to 5:50 PM. This announcement signals the company's continued commitment to returning value to shareholders through regular dividend payouts.
Shareholders holding shares as of the record date (August 8, 2025) will receive Rs. 4 per share, providing a short-term income benefit. The timely declaration of an interim dividend reflects healthy cash flows and a shareholder-friendly capital allocation policy, which is generally viewed positively by the market.